Mary A Gerend1, Melissa A Shepherd2, Mia Liza A Lustria3, Janet E Shepherd4. 1. Department of Behavioral Sciences & Social Medicine, Florida State University College of Medicine, Tallahassee, Florida, USA Departments of Medical Social Sciences and Psychology, Northwestern University, Chicago, Illinois, USA. 2. Department of Psychology, Florida State University, Tallahassee, Florida, USA. 3. College of Communication & Information, Florida State University, Tallahassee, Florida, USA. 4. Department of Clinical Sciences, Florida State University College of Medicine, Tallahassee, Florida, USA.
Abstract
BACKGROUND: Although physician recommendation is one of the strongest predictors of human papillomavirus (HPV) vaccination, it is unclear for whom physicians are recommending the vaccine. To help guide intervention efforts, this study investigated predictors of participant-reported physician recommendation for HPV vaccine among young adults in the USA. METHODS: Women and men (N=223) aged 18-26 years were recruited online through Craigslist, a popular classified advertisements website. Ads were posted in the 25 largest US cities from September 2013 to March 2014. Participants completed a survey that assessed demographic and sociopolitical characteristics, sexual history, HPV vaccination history, and whether they had ever received a recommendation for HPV vaccine from a physician or healthcare provider. RESULTS: Fifty-three per cent reported receiving a recommendation for HPV vaccine and 45% had received ≥1 dose of HPV vaccine. Participants who received a recommendation were over 35 times more likely to receive ≥1 dose of HPV vaccine relative to participants without a recommendation. Bivariable and multivariable correlates of provider recommendation were identified. Results from the multivariable model indicated that younger (aged 18-21 years), female, White participants with health insurance (ie, employer-sponsored or some other type such as military-sponsored) were more likely to report receiving a recommendation for HPV vaccine. CONCLUSIONS: Results suggest that physician recommendation practices for HPV vaccination vary by characteristics of the patient. Findings underscore the key role of the healthcare provider in promoting HPV vaccination and have important implications for future HPV vaccine interventions with young adults. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
BACKGROUND: Although physician recommendation is one of the strongest predictors of human papillomavirus (HPV) vaccination, it is unclear for whom physicians are recommending the vaccine. To help guide intervention efforts, this study investigated predictors of participant-reported physician recommendation for HPV vaccine among young adults in the USA. METHODS:Women and men (N=223) aged 18-26 years were recruited online through Craigslist, a popular classified advertisements website. Ads were posted in the 25 largest US cities from September 2013 to March 2014. Participants completed a survey that assessed demographic and sociopolitical characteristics, sexual history, HPV vaccination history, and whether they had ever received a recommendation for HPV vaccine from a physician or healthcare provider. RESULTS: Fifty-three per cent reported receiving a recommendation for HPV vaccine and 45% had received ≥1 dose of HPV vaccine. Participants who received a recommendation were over 35 times more likely to receive ≥1 dose of HPV vaccine relative to participants without a recommendation. Bivariable and multivariable correlates of provider recommendation were identified. Results from the multivariable model indicated that younger (aged 18-21 years), female, White participants with health insurance (ie, employer-sponsored or some other type such as military-sponsored) were more likely to report receiving a recommendation for HPV vaccine. CONCLUSIONS: Results suggest that physician recommendation practices for HPV vaccination vary by characteristics of the patient. Findings underscore the key role of the healthcare provider in promoting HPV vaccination and have important implications for future HPV vaccine interventions with young adults. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Authors: Sophia R Newcomer; James Caringi; Beth Jones; Emily Coyle; Timothy Schehl; Matthew F Daley Journal: Public Health Rep Date: 2020-09-24 Impact factor: 2.792
Authors: Nelia M Afonso; Maurice J Kavanagh; Stephanie M Swanberg; Jeanne M Schulte; Tracy Wunderlich; Victoria C Lucia Journal: BMC Public Health Date: 2017-01-06 Impact factor: 3.295
Authors: Carmen H Logie; Ashley Lacombe-Duncan; Philip Baiden; Peter A Newman; Suchon Tepjan; Clara Rubincam; Nick Doukas; Farid Asey Journal: BMJ Open Date: 2018-04-20 Impact factor: 2.692
Authors: Terra Forward; Elissa Meites; John Lin; James P Hughes; Elizabeth R Unger; Lauri E Markowitz; Matthew Golden; Fred Swanson; Paul M Faestel; Rachel L Winer Journal: Sex Transm Dis Date: 2022-01-01 Impact factor: 2.830